Recce Pharmaceuticals Ltd.ASX: RCE

Recce Pharmaceuticals: Notice of Annual General Meeting/Proxy Form

· Issued by Recce Pharmaceuticals Ltd. via ASX

Filed with ASX · · 43 pages · English

Summary by 6ix AI

Recce Pharmaceuticals Ltd. has issued a notice for its upcoming Annual General Meeting, detailing important information for shareholders regarding the event. The meeting is scheduled to take place at a specific venue and will also be accessible virtually, allowing shareholders to vote and ask questions. The agenda includes the adoption of the Remuneration Report, election and re-election of directors, and various resolutions related to the company's operations. Shareholders are encouraged to submit questions in advance and to participate in the voting process either in person or online.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Notice of 2026 Annual General Meeting Sydney, Australia, 7 October 2026: Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), attaches the following documents in relation to its 2026 Annual General Meeting: 1. Notice of 2026 Annual General Meeting (Notice); 2. Proxy Form; and 3. Access...

Recce Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases